```markdown
July/2024

सत्यमेव जयते
Department of Health Research
Ministry of Health and Family Welfare, Government of India

AN CO
OF MEDICA
icma
INDIAN COUNCIL OF
MEDICAL RESEARCH
Serving

# Standard Treatment Workflow (STW)
## ACUTE RHEUMATIC FEVER
ICD-10-101.9

**Rheumatic fever (RF)** is an acute, nonsuppurative inflammatory disease complicating untreated
or partially treated **Group A Streptococcus (GAS)** pharyngitis

### PATHOPHYSIOLOGY

**Risk factors:**
*   Overcrowding
*   Poor orodental & personal hygiene limited
    access to healthcare

**Precipitating event:**
*   **Group A Streptococcal pharyngitis**

**Susceptible host:**
*   School going children
    (5-15 years age)

Repeated group A
Streptococcus infections
Priming of immune response

First
episode
of ARF

RHD

Molecular mimicry between group A
Streptococcus antigens and host tissues

Exaggerated T-cell mediated immune
response

### CLINICAL PRESENTATION

**Arthritis (80%)** - Most common manifestation
*   Multiple joints
    *   Migratory - lasts <1 week in a joint
    *   Large joints - ankles, knees & wrist
*   Exquisite tenderness with redness & swelling
*   Prompt response to **NSAIDS**
*   Leaves no deformity

**Carditis (50%)** - Most devastating manifestation
*   Tachycardia
*   Dyspnoea
*   Heart Failure
*   Murmur on auscultation

**Subcutaneous nodules** - rare
*   Painless, pea-sized, hard nodules
*   On extensor surfaces of limbs, skull and back

**Erythema marginatum (5%)**
*   Transient pink macule with fading centre
*   Mostly located on the trunk and limbs

**Chorea (10%)** - 2-6 months after streptococcal sore
throat
*   Quasipurposive, involuntary movements with
    emotional lability
*   Best seen in hands, arms, tongue and face
*   Affects fine motor movement like handwriting

### DIAGNOSIS BASED ON JONES CRITERIA

For all patient populations with evidence of preceding **group A streptococcal infection**

**Diagnosis:**
*   Initial **ARF**
*   Recurrent **ARF**
*   Recurrent **ARF** in **RHD**

| Criteria                | Low-risk populationsa                                                                          | Moderate and high-risk populationsa                                                                             |
| :---------------------- | :--------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------------------- |
| **Major**               |                                                                                                |                                                                                                               |
|                         | 2 major or 1 major plus 2 minor Criteria                                                     |                                                                                                               |
|                         | 2 major or 1 major and 2 minor or 3 minor Criteria                                               |                                                                                                               |
|                         | 2 minor (No major criteria needed)                                                           |                                                                                                               |
|                         | **Carditis** (Clinical and/or subclinical)b                                                    | **Carditis** (Clinical and/or subclinical)b                                                                     |
|                         | **Arthritis** (Polyarthritis only)                                                              | **Arthritis** (Monoarthritis or polyarthritis or polyarthralgia)                                                     |
|                         | **Chorea**                                                                                       | **Chorea**                                                                                                    |
|                         | **Erythema marginatum**                                                                        | **Erythema marginatum**                                                                                      |
|                         | **Subcutaneous nodules**                                                                      | **Subcutaneous nodules**                                                                                   |
| **Minor**               |                                                                                                |                                                                                                               |
|                         | **Polyarthralgia**                                                                             | **Monoarthralgia**                                                                                            |
|                         | Fever (≥38.5°C)                                                                                 | Fever (≥38°C)                                                                                                |
|                         | **ESR** >60 mm/h and/or **CRP** ≥3 mg/dL                                                           | **ESR** >30 mm/h and/or **CRP** ≥3 mg/dL                                                                      |
|                         | Prolonged **PR** on **ECG** (for age)   (unless carditis is a major criterion)                 | Prolonged **PR** on **ECG** (for age)   (unless carditis is a major criterion)                                 |
| **Essential**           | Throat culture or antigen positive for streptococcal sore throat OR elevated **ASO** titers   |                                                                                                               |
|                         | (>320 U)                                                                                       |                                                                                                               |

aLow-risk populations **ARF** incidence ≤2/
per 100 000 school-aged children or all-age
**RHD** prevalence of ≤1/per 1000 population
per year

bSubclinical **carditis** is pathological
echocardiographic valvulitis

**Polyarthralgia** should only be considered
as a major manifestation in moderate-to
high-risk populations after exclusion of
other conditions. Joint manifestations can
only be considered in either the major or
minor categories but not both in the same
patient

**Erythema marginatum** and **subcutaneous
nodules** are 'stand-alone major criteria

### LABORATORY INVESTIGATIONS

| Essential              | Optional              | DIFFERENTIAL DIAGNOSIS                                                                                                                                                                                                                                               |
| :--------------------- | :-------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Throat swab antigen    | Anti DNAse-B          | 1. Pediatric autoimmune neuropsychiatric disorders (**PANDAS**) -autoimmune disorder                                                                                                                                                                                    |
| Throat swab culture    | **TLC**, **DLC**      | 2. Post streptococcal reactive arthritis (**PSRA**)-small joint arthritis, poor response to **NSAIDS**                                                                                                                                                                   |
| Anti-streptolysin **O** | **ESR**, **CRP**      | 3. Juvenile rheumatoid arthritis                                                                                                                                                                                                                                       |
| **ECG** (12 lead)      | Chest X ray           | 4. Infective endocarditis                                                                                                                                                                                                                                             |
|                        | Echocardiogram ↑      |                                                                                                                                                                                                                                                                      |

LV
AML
RV
PML
LA
RV
LV
heheheheh
P
P
P

---

July/2024

सत्यमेव जयते
Department of Health Research
Ministry of Health and Family Welfare, Government of India

AN CO
OF MEDICA
icma
INDIAN COUNCIL OF
MEDICAL RESEARCH
Serving

# Standard Treatment Workflow (STW)
## ACUTE RHEUMATIC FEVER
(Continued)

### MANAGEMENT

| Agent                                     | Primary prophylaxis (to Eradicate streptococcus) |           |
| :---------------------------------------- | :--------------------------------------------- | :-------- |
| **Benzathine penicillin (Penicillin G)** | ≤27kg 6,00,000U >27kg 12,00,000U               | **Dose**  |
|                                           |                                                | Duration  |
|                                           |                                                | Once      |
| **Phenoxymethyl penicillin (Penicillin V)** | ≤27kg 250mg/dose <27kg 500mg/dose              | or        |
|                                           |                                                | 10 days   |
| For individuals allergic to penicillin    |                                                |           |
| **Amoxicillin**                           | 25-50mg/kg/day divided into 3 doses (maximum 1g/day) | 10 days   |
| **Erythromycin**                          | 20-40mg/kg/day divided into 2-4 doses (maximum 1g/day) |           |

### Anti-inflammatory therapy & supportive care

Confirmed diagnosis of **Acute Rheumatic Fever**

Primary prophylaxis
Primary manifestation (monitor for carditis in all patients)

```mermaid
graph TD
    A[Polyarthritis
Monoarthritis
(in moderate - high risk populations)] --> B{Start NSAIDS or
    Salicylates};
    B --> C{Check for
    carditis};
    C --> D{Carditis};
    C --> E[Chorea];
    D --> F{Subclinical/Mild};
    D --> G{Moderate/severe
    (heart failure)};
    F --> H{Response to
    treatment};
    G --> I[Prednisolone 8-12
    weeks];
    I --> J{Heart failure treatment
    (bed rest, diuretics,
    digoxin vasodilators, etc)};
    J --> K{Response to
    treatment?};
    K --> L{Monitor for
    activity rebound};
    L -- Yes --> M[Secondary prophylaxis];
    L -- No --> N[Refer to ARF/RHD expert];
    B --> Z{Salicylates 4-6
    weeks};
    Z --> H;
    H -- Yes --> O[Continue for 2-4 weeks];
    O --> Q{Taper doses};
    I --> P{Taper dose};
    P --> Q;
    Q --> R{Monitor for activity rebound};

```

| Clinical Manifestation    | Treatment Schedule                                                                                                                                           | Duration                                         |
| :------------------------ | :--------------------------------------------------------------------------------------------------------------------------------------------------------- | :----------------------------------------------- |
| Moderate/Severe carditis  | **Prednisolone** 2mg/kg/day once daily (Aspirin while tapering **Prednisolone**)                                                                         | 8-12 WKS                                         |
| Mild carditis             | Aspirin 75-100mg/day divided into 4 doses                                                                                                                    | 2-4 WKS                                          |
| Polyarthritis             | Aspirin 75-100mg/day divided into 4 doses or **Naproxen** 10-20mg/kg/day                                                                                    | 2-4 WKS                                          |
| Chorea                    | **Carbamazepine** 4-10mg/kg/day or **Valproic acid** 20-30mg/kg/day or **Haloperidol** 2-6mg/day                                                              | Variable depending upon the need of the patient |

### Secondary prophylaxis

| Category of Patient                               | Duration                                                                                                                                               | Agent                                          | Dose                                                      | Route           |
| :------------------------------------------------ | :----------------------------------------------------------------------------------------------------------------------------------------------------- | :--------------------------------------------- | :-------------------------------------------------------- | :-------------- |
| Patients without carditis                         | 5 years after the last **ARF** episode or until 21 years age (whichever is longer)                                                                     | **Benzathine penicillin** (Penicillin G)       | ≤27kg 6,00,000U >27kg 12,00,000U                        | Intramuscular   |
|                                                   |                                                                                                                                                      | or                                             |                                                           |                 |
| Patients with carditis but no **RHD**           | 10 years after the last acute episode or until 25 years age (whichever is longer)                                                                       | **Phenoxymethyl penicillin** (penicillin V)   | 250mg twice daily                                       | Oral            |
| Patients with **RHD** who have undergone valve surgery (repair or replacement) | At least until 40 years age (preferably lifelong)                                                                                      |                                                |                                                           |                 |
|                                                   |                                                                                                                                                      | For individuals allergic to penicillin        |                                                           |                 |
|                                                   |                                                                                                                                                      | **Erythromycin**                               | 250mg twice daily                                       | Oral            |

### ABBREVIATIONS

**ARF**: Acute Rheumatic Fever
**ASO**: Antistreptolysin O
**CRP**: C-reactive protein
**DLC**: Differential Leukocyte Count
**ECG**: Electrocardiogram
**ESR**: Erythrocyte Sedimentation Rate
**NSAIDs**: Non-Steroidal Anti-Inflammatory Drugs
**PANDAS**: Pediatric Autoimmune Neuropsychiatric
Disorders Associated with Streptococcal Infections
**RHD**: Rheumatic Heart Disease
**TLC**: Total Leukocyte Count

### REFERENCES
1.  Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, Remenyi B, Taubert KA, Bolger AF, Beerman L, Mayosi BM, Beaton A, Pandian NG, Kaplan EL;
    American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease of the Young. Revision of the
    Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation.
    2015 May 19;131(20):1806-18. doi: 10.1161/CIR.0000000000000205. Epub 2015 Apr 23. Erratum in: Circulation. 2020 Jul 28;142(4):e65. PMID: 25908771.
2.  Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, Regmi PR, Reményi B, Sliwa-Hähnle K, Zühlke LJ, Sable C; American Heart Association Council on
    Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Contemporary
    Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association. Circulation. 2020
    Nov 17;142(20):e337-e357. doi: 10.1161/CIR.0000000000000921. Epub 2020 Oct 19. Erratum in: Circulation. 2021 Jun 8;143(23):e1025-e1026. PMID: 33073615.
3.  Handbook on prevention and control of rheumatic fever and rheumatic heart diseases. Directorate General of Health Services. Government of India 2015. accessed online
    on July 18, 2023.

**INJECTABLE PENICILLIN IS SAFE; ALLERGY IS UNCOMMON**

This STW has been prepared by national experts of India with feasibility considerations for various levels of healthcare system in the country. These broad guidelines are advisory, and are based on expert
opinions and available scientific evidence. There may be variations in the management of an individual patient based on his/her specific condition, as decided by the treating physician. There will be no
indemnity for direct or indirect consequences. Kindly visit the website of ICMR for more information: (icmr.gov.in) for more information. Indian Council of Medical Research, Ministry of Health & Family
Welfare, Government of India.
```